These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 455177)

  • 1. Accredited pharmaceutical manufacturers representatives.
    Bell W
    Can Med Assoc J; 1979 Jun; 120(11):1327. PubMed ID: 455177
    [No Abstract]   [Full Text] [Related]  

  • 2. Accreditation program geared to broaden scope of pharmaceutical representatives.
    Can Hosp; 1970 Jan; 47(1):53. PubMed ID: 5434682
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter. APMR (Accredited Pharmaceutical Manufacturers Representative).
    Eade NR
    Can Med Assoc J; 1973 Sep; 109(5):346 passim. PubMed ID: 4742470
    [No Abstract]   [Full Text] [Related]  

  • 4. The self-perceived role and educational needs of pharmaceutical representatives: a survey.
    O'Donnell MJ; Molloy DW; Smith SD; Dubois S; Russo RM
    Educ Health (Abingdon); 2004 Nov; 17(3):339-45. PubMed ID: 15848821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
    Desjardins JG
    CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Code of marketing practices. Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada.
    Lexchin J
    Can Fam Physician; 1997 Nov; 43():1997. PubMed ID: 9386886
    [No Abstract]   [Full Text] [Related]  

  • 9. "Disinformation" from pharmaceutical company representatives.
    Gordon M
    CMAJ; 1990 Sep; 143(5):370. PubMed ID: 2390749
    [No Abstract]   [Full Text] [Related]  

  • 10. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. America's pharmaceutical research companies: keeping the cost of health care down. Pharmaceutical Manufacturers Association.
    Hawaii Med J; 1992 Jan; 51(1):15-16, 19. PubMed ID: 1740387
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-based training for pharmaceutical manufacturers' representatives.
    Powell SH; Stempien MJ; Vogenberg FR
    Am J Hosp Pharm; 1984 Jan; 41(1):70, 74. PubMed ID: 6695935
    [No Abstract]   [Full Text] [Related]  

  • 14. Do pharmaceutical representatives misuse their drug samples?
    Tong KL; Lien CY
    Can Fam Physician; 1995 Aug; 41():1363-6. PubMed ID: 7580385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-based training for pharmaceutical manufacturers' representatives.
    Phillips DJ; Smith JE
    Am J Hosp Pharm; 1983 Oct; 40(10):1661-3. PubMed ID: 6638029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications to the National Dental Examining Board of Canada's certification process.
    Gerrow JD; Boyd MA; Donaldson D; Watson PA; Henderson B
    J Can Dent Assoc; 1998 Feb; 64(2):98-100, 102-3. PubMed ID: 9509815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Fam Pract; 2005 Dec; 22(6):624-30. PubMed ID: 16055474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accreditation of pharmaceutical education: state of health.
    Provost GP
    Am J Hosp Pharm; 1973 Mar; 30(3):205. PubMed ID: 4690477
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.